technology
ASCO Breakthrough 2026 Wrap-Up: Precision Oncology, AI, and Biomarkers Define the ...
PushButton AI Team ·
Cancer doctors just figured out something every business owner needs to hear about AI. They stopped asking "how do we use AI?" and started asking "where does AI actually change outcomes?" You've pro
Cancer doctors just figured out something every business owner needs to hear about AI.
They stopped asking "how do we use AI?" and started asking "where does AI actually change outcomes?"
You've probably felt this. You bought a tool, it sat unused, and now you're $200/month wiser and twice as skeptical. That's not a failure of intelligence — it's what happens when nobody gives you a specific problem to solve first.
Here's what oncologists learned: AI only works when it's matched to a measurable signal. In medicine, that's a biomarker. In your business, that's a bottleneck with a number attached to it.
Not "we want to be more efficient." Something like: "Our team spends 11 hours a week writing proposals that close at 22%."
That's your biomarker. That's where AI earns its seat at the table.
This week, pick one repetitive task your team complains about. Time it. Write down what good looks like. That single step separates business owners who get ROI from AI from those still watching demos.
You don't need to overhaul anything. You need one problem, clearly defined.
What's the task you keep wishing someone else could handle — what's stopped you from automating it?
#AIStrategy #SmallBusiness #BusinessGrowth #AIImplementation
Original Source
AI is becoming increasingly integrated into routine oncology practice. Biomarkers such as ctDNA and MRD are moving closer to directing treatment ...